Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay.

J Breast Cancer · 2022 · PMC9807325 · PMID 36479604

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

marginally significantp = 0.054so close (0.05 < p ≤ 0.1)

A more than 1+ score of Ki-67 was a marginally significant factor ( p = 0.054; 2.74 [0.99–7.79]), and BCT score was the only significant factor related to tumor response in the multivariate analysis ( p = 0.016; 4.18 [1.34–14.28]).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.